Antibody-drug conjugate and free geldanamycin combination therapy enhances anti-cancer efficacy
Jessica R. McCombs, Hsuan‐Ping Chang, Dhaval K. Shah, Shawn C. Owen
Topics & Concepts
CytotoxicityGeldanamycinPharmacologyEndosomeCancer researchChemistryConjugateAntibody-drug conjugateHsp90AntibodyMedicineCellImmunologyHeat shock proteinBiochemistryIn vitroMonoclonal antibodyMathematicsGeneMathematical analysisToxin Mechanisms and ImmunotoxinsHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research